{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:46:26Z","timestamp":1763117186014,"version":"3.45.0"},"reference-count":24,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: The management of asymptomatic bacteriuria (ASB) and candiduria (ASC) in kidney transplant recipients during the early post-transplant period is controversial. This study aimed to evaluate whether treating, versus not treating, ASB and ASC episodes in the first two months after kidney transplantation influences clinical outcomes and the emergence of multidrug-resistant (MDR) infections. Methods: We conducted a single-center retrospective cohort study enrolling patients with ASB or ASC occurring in the first two months after kidney transplantation between January 2019 and July 2024. Patients were classified into treated and untreated groups. The primary endpoint was 30-day mortality. Secondary endpoints included mortality at 90, 180 and 360 days; incidence of sepsis or septic shock; bacteremia\/candidemia, hospitalization, graft loss; decline in renal function, urinary tract infections (UTIs), recurrent UTI and rate of MDR colonization\/infection. Results: We enrolled 59 kidney transplant recipients and observed 147 episodes of ASB\/ASC. Of the 147 episodes, 95 were untreated and 52 were treated. No significant differences were observed between treated and untreated patients in 30-day (2.1% vs. 3.8%) or 90-day mortality (2.1% vs. 1.9%), nor in any of the secondary clinical outcomes. However, patients who received treatment tended to have a higher rate of MDR colonization\/infection (63% vs. 46%). MDR pathogen isolation was significantly associated with increased risks of septic shock (OR 4.639, p = 0.04), bacteremia\/candidemia (OR 3.734, p = 0.01), hospitalization (OR 2.183, p = 0.03) and renal function deterioration (OR 3.93, p = 0.03). Conclusions: Antimicrobial treatment of ASB and ASC in the early post-transplant period would seem not to confer clinical benefit and may be associated with the risk of MDR colonization\/infection.<\/jats:p>","DOI":"10.3390\/antibiotics14111155","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:07:03Z","timestamp":1763114823000},"page":"1155","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact of Treating Versus Not Treating Asymptomatic Bacteriuria\/Candiduria in the First Two Months After Kidney Transplantation"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-5434","authenticated-orcid":false,"given":"Biagio","family":"Pinchera","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Carrano","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Public Health, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0523-7441","authenticated-orcid":false,"given":"Isabella","family":"Di Filippo","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Presidio Ospedaliero \u201cA. Cardarelli\u201d, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0723-495X","authenticated-orcid":false,"given":"Vincenzo","family":"Fotticchia","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Petrone","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Antimo","family":"Alf\u00e8","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmarco","family":"Borriello","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Public Health, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amerigo","family":"Piccione","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Public Health, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Salemi","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Public Health, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-8451","authenticated-orcid":false,"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/ndt\/gfy078","article-title":"Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: A survey of current practice in Europe","volume":"33","author":"Coussement","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e13507","DOI":"10.1111\/ctr.13507","article-title":"Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Goldman","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cmi.2020.09.005","article-title":"Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): A pragmatic, multicentre, randomized, controlled trial","volume":"27","author":"Coussement","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ajt.2023.07.009","article-title":"A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study","volume":"23","author":"Silva","year":"2023","journal-title":"Am. J. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ajt.13075","article-title":"Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients","volume":"15","author":"Bodro","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QCO.0000000000000488","article-title":"Multidrug-resistant Gram-negative infection in solid organ transplant recipients: Implications for outcome and treatment","volume":"31","author":"Silva","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"ofz243","DOI":"10.1093\/ofid\/ofz243","article-title":"Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial","volume":"6","author":"Oriol","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study","volume":"71","author":"Stampf","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-012-1727-2","article-title":"Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: Retrospective observational study","volume":"32","author":"Green","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/ndt\/gfr198","article-title":"Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients","volume":"26","author":"Hadaya","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s15010-015-0743-4","article-title":"Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients","volume":"43","author":"Freire","year":"2015","journal-title":"Infection"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/TP.0b013e3182a049fd","article-title":"Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients","volume":"96","author":"Bodro","year":"2013","journal-title":"Transplantation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/tri.12711","article-title":"Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice","volume":"29","author":"Naik","year":"2016","journal-title":"Transpl. Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ozawa, K., Takai, M., Taniguchi, T., Kawase, M., Takeuchi, S., Kawase, K., Kato, D., Iinuma, K., Nakane, K., and Koie, T. (2022). Diabetes Mellitus as a Predictive Factor for Urinary Tract Infection for Patients Treated with Kidney Transplantation. Medicina, 58.","DOI":"10.3390\/medicina58101488"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Santithanmakorn, C., Vanichanan, J., Townamchai, N., Jutivorakool, K., Wattanatorn, S., Sutherasan, M., Opanuruk, J., Kerr, S.J., Praditpornsilpa, K., and Avihingsanon, Y. (2022). Bacterial Urinary Tract Infection and Early Asymptomatic Bacteriuria in Kidney Transplantation Still Negatively Affect Kidney Transplant Outcomes in the Era of Modern Immunosuppression and Cotrimoxazole Prophylaxis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112984"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/tid.12547","article-title":"Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: Narrowing of the therapeutic options","volume":"18","author":"Morales","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.4103\/1319-2442.301197","article-title":"Multiple Drug Resistant Urinary Tract Infection in Kidney Transplant Recipients: A Retrospective Cohort Study","volume":"31","author":"Hamid","year":"2020","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e12757","DOI":"10.1111\/tid.12757","article-title":"Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation","volume":"19","author":"Varotti","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/tid.12276","article-title":"Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: A case-control study","volume":"16","author":"Simkins","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/tid.12450","article-title":"Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients","volume":"17","author":"Pouch","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/11\/1155\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:40:48Z","timestamp":1763116848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/11\/1155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["antibiotics14111155"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14111155","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}